Invesaro

Stocks Comparison

Cme vs Marex: revenue, profit, margins and growth compared

Cme brought in $6.5B of revenue in fiscal 2025, Marex $2B in fiscal 2025. Revenue changed by +6.4% at Cme and +26.9% at Marex on the year before, so Marex grew faster. Cme kept 62.5% of its revenue as net profit, Marex 14.5%. Free cash flow was $4.2B at Cme and $654.4M at Marex.

Side by side, latest fiscal year

CMEMRX
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$6.5B$2B
Revenue growth+6.4%+26.9%
Net income$4.1B$293.9M
Net margin62.5%14.5%
Free cash flow$4.2B$654.4M
Free cash flow margin64.3%32.3%
Earnings per share (diluted)$11.16$3.86
Cash$4.4B$2.9B
Debtn/a$200M
Price to earnings23.7n/a
Market value$95.1B$5.3B
Dividend yield1.89%n/a
Rank by revenue in sector#84 of 444 · Finance#144 of 444 · Finance

Over the years

Revenue
CME FY2018: $4.3BCME FY2019: $4.9BCME FY2020: $4.9BCME FY2021: $4.7BCME FY2022: $5BCME FY2023: $5.6BCME FY2024: $6.1BCME FY2025: $6.5BMRX FY2022: $711.1MMRX FY2024: $1.2BMRX FY2024: $1.6BMRX FY2025: $2BFY18FY19FY20FY21FY22FY23FY24FY25
CME $6.5BMRX $2B
Net income
CME FY2018: $2BCME FY2019: $2.1BCME FY2020: $2.1BCME FY2021: $2.6BCME FY2022: $2.7BCME FY2023: $3.2BCME FY2024: $3.5BCME FY2025: $4.1BMRX FY2022: $91.6MMRX FY2024: $128MMRX FY2024: $204.7MMRX FY2025: $293.9MFY18FY19FY20FY21FY22FY23FY24FY25
CME $4.1BMRX $293.9M
Net margin
CME FY2018: 45.5%CME FY2019: 43.5%CME FY2020: 43.1%CME FY2021: 56.2%CME FY2022: 53.6%CME FY2023: 57.8%CME FY2024: 57.5%CME FY2025: 62.5%MRX FY2022: 12.9%MRX FY2024: 10.3%MRX FY2024: 12.8%MRX FY2025: 14.5%FY18FY19FY20FY21FY22FY23FY24FY25
CME 62.5%MRX 14.5%
Revenue growth
CME FY2019: +13.0%CME FY2020: +0.3%CME FY2021: -4.0%CME FY2022: +7.0%CME FY2023: +11.1%CME FY2024: +9.9%CME FY2025: +6.4%MRX FY2024: +75.0%MRX FY2024: +28.1%MRX FY2025: +26.9%FY19FY20FY21FY22FY23FY24FY25
CME +6.4%MRX +26.9%
Free cash flow
CME FY2018: $2.3BCME FY2019: $2.4BCME FY2020: $2.5BCME FY2021: $2.3BCME FY2022: $3BCME FY2023: $3.4BCME FY2024: $3.6BCME FY2025: $4.2BMRX FY2022: $222MMRX FY2024: $726MMRX FY2024: $1.2BMRX FY2025: $654.4MFY18FY19FY20FY21FY22FY23FY24FY25
CME $4.2BMRX $654.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cme and Marex

Which is bigger by revenue, Cme or Marex?

Cme is bigger by revenue: $6.5B in fiscal 2025, against $2B for Marex in fiscal 2025.

Which keeps more of its revenue as profit, Cme or Marex?

Cme had a net margin of 62.5% in fiscal 2025; Marex had 14.5% in fiscal 2025.

Which grew revenue faster, Cme or Marex?

In their latest fiscal years revenue changed by +6.4% at Cme and +26.9% at Marex.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies